Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Humana
HUM
|
$1.34B |
| 2 |
SBA Communications
SBAC
|
$1.17B |
| 3 |
Avantor
AVTR
|
$647M |
| 4 |
Fortive
FTV
|
$583M |
| 5 |
Celanese
CE
|
$472M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.29B |
| 2 |
Wells Fargo
WFC
|
$1.16B |
| 3 |
Truist Financial
TFC
|
$1.11B |
| 4 |
Bank of America
BAC
|
$973M |
| 5 |
Goldman Sachs
GS
|
$864M |
Sector Composition
| 1 | Healthcare | 21.28% |
| 2 | Financials | 18.77% |
| 3 | Industrials | 12.45% |
| 4 | Technology | 12.31% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
GSK
GSK
$79.9B
| $2.31B | 1.35% | 68,440,912 +353,749 | +0.5% | +$12M |
|
27
TE Connectivity
TEL
$61B
| $2.28B | 1.33% | 15,965,609 -24,577 | -0.2% | -$3.51M |
|
|
28
Alphabet (Google) Class A
GOOGL
$2.57T
| $2.27B | 1.32% | 12,005,162 +16,345 | +0.1% | +$3.09M |
|
29
UBS Group
UBS
$128B
| $2.24B | 1.3% | 73,497,042 +125,600 | +0.2% | +$3.82M |
|
30
Meta Platforms (Facebook)
META
$1.86T
| $2.23B | 1.3% | 3,810,837 -1,877 | -0% | -$1.1M |
|
|
31
Goldman Sachs
GS
$226B
| $2.22B | 1.29% | 3,870,536 -1,509,556 | -28% | -$864M |
|
|
32
Avantor
AVTR
$9.18B
| $2.09B | 1.22% | 99,145,770 +30,727,673 | +45% | +$647M |
|
33
T-Mobile US
TMUS
$284B
| $2.07B | 1.21% | 9,382,681 -188,368 | -2% | -$41.6M |
|
34
UnitedHealth
UNH
$281B
| $2.07B | 1.21% | 4,093,228 +191,018 | +5% | +$96.6M |
|
35
Zimmer Biomet
ZBH
$21B
| $2.02B | 1.18% | 19,118,436 +2,044,645 | +12% | +$216M |
|
36
AB InBev
BUD
$122B
| $2B | 1.17% | 39,996,830 +8,670,940 | +28% | +$434M |
|
37
Williams Companies
WMB
$70.7B
| $1.97B | 1.14% | 36,348,514 -923,112 | -2% | -$50M |
|
38
Air Products & Chemicals
APD
$65.5B
| $1.93B | 1.12% | 6,663,154 +64,960 | +1% | +$18.8M |
|
39
Baker Hughes
BKR
$44.8B
| $1.87B | 1.09% | 45,658,130 -172,108 | -0.4% | -$7.06M |
|
40
Haleon
HLN
$43.9B
| $1.71B | 0.99% | 178,744,926 -427,457 | -0.2% | -$4.08M |
|
41
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.65B | 0.96% | 2,321,316 +9,381 | +0.4% | +$6.68M |
|
|
42
SBA Communications
SBAC
$22B
| $1.5B | 0.87% | 7,346,255 +5,722,740 | +352% | +$1.17B |
|
43
Baxter International
BAX
$12.7B
| $1.47B | 0.85% | 50,377,294 +5,779,100 | +13% | +$169M |
|
44
Cognizant
CTSH
$35.3B
| $1.41B | 0.82% | 18,330,397 -19,177 | -0.1% | -$1.47M |
|
45
Cisco
CSCO
$274B
| $1.41B | 0.82% | 23,738,670 -82,877 | -0.3% | -$4.91M |
|
|
46
Bank of America
BAC
$376B
| $1.37B | 0.79% | 31,060,084 -22,147,719 | -42% | -$973M |
|
47
GE HealthCare
GEHC
$33.7B
| $1.3B | 0.76% | 16,675,508 +11,867 | +0.1% | +$928K |
|
48
LyondellBasell Industries
LYB
$18.1B
| $1.26B | 0.73% | 16,965,832 +851,365 | +5% | +$63.2M |
|
49
Alibaba
BABA
$322B
| $1.23B | 0.71% | 14,469,770 -3,616,800 | -20% | -$307M |
|
50
Dominion Energy
D
$51.1B
| $1.22B | 0.71% | 22,623,133 -64,740 | -0.3% | -$3.49M |
|